Search alternatives:
significant change » significant changes (Expand Search), significant challenge (Expand Search), significant challenges (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
change decrease » change increases (Expand Search), change degree (Expand Search)
based decrease » caused decreased (Expand Search), marked decrease (Expand Search), based defense (Expand Search)
significant change » significant changes (Expand Search), significant challenge (Expand Search), significant challenges (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
change decrease » change increases (Expand Search), change degree (Expand Search)
based decrease » caused decreased (Expand Search), marked decrease (Expand Search), based defense (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Box plot displaying the distributions of the deconvolution derived proportions of cell types.
Published 2024Subjects: -
15
Spearman correlation of age with proportions of cell types in men, for each brain region.
Published 2024Subjects: -
16
Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA....
Published 2025“…Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. …”
-
17
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
18
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
19
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
20